BPMC logo

Blueprint Medicines (BPMC) Operating Expenses

Annual Operating Expenses

$722.86 M
+$8.07 M+1.13%

December 31, 2023


Summary


Performance

BPMC Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBPMCexpensesmetrics:

Quarterly Operating Expenses

$175.23 M
+$1.62 M+0.93%

September 30, 2024


Summary


Performance

BPMC Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBPMCexpensesmetrics:

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

BPMC Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+1.1%-3.2%
3 y3 years+49.2%-3.7%
5 y5 years+147.9%-3.7%

BPMC Operating Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-9.2%+1.1%-57.4%+9.4%
5 y5-year-9.2%+69.0%-57.4%+57.0%
alltimeall time-9.2%+3342.2%-57.4%+2420.2%

Blueprint Medicines Operating Expenses History

DateAnnualQuarterly
Sep 2024
-
$175.23 M(+0.9%)
Jun 2024
-
$173.61 M(+1.1%)
Mar 2024
-
$171.75 M(-2.9%)
Dec 2023
$722.86 M(+1.1%)
$176.85 M(-2.3%)
Sep 2023
-
$180.99 M(-0.6%)
Jun 2023
-
$181.99 M(-0.6%)
Mar 2023
-
$183.02 M(+0.6%)
Dec 2022
$714.79 M(-10.2%)
$181.86 M(-2.0%)
Sep 2022
-
$185.59 M(-0.8%)
Jun 2022
-
$187.15 M(+16.8%)
Mar 2022
-
$160.19 M(-61.0%)
Dec 2021
$796.33 M(+64.3%)
$411.08 M(+206.3%)
Sep 2021
-
$134.22 M(+3.8%)
Jun 2021
-
$129.31 M(+6.2%)
Mar 2021
-
$121.71 M(+1.5%)
Dec 2020
$484.60 M(+13.3%)
$119.94 M(+7.5%)
Sep 2020
-
$111.61 M(-16.2%)
Jun 2020
-
$133.25 M(+11.2%)
Mar 2020
-
$119.80 M(-0.9%)
Dec 2019
$427.84 M
$120.91 M(+12.9%)
Sep 2019
-
$107.10 M(-1.8%)
Jun 2019
-
$109.02 M(+20.1%)
DateAnnualQuarterly
Mar 2019
-
$90.80 M(+7.9%)
Dec 2018
$291.55 M(+68.8%)
$84.17 M(+9.9%)
Sep 2018
-
$76.60 M(+8.0%)
Jun 2018
-
$70.91 M(+18.4%)
Mar 2018
-
$59.87 M(+15.7%)
Dec 2017
$172.67 M(+72.1%)
$51.72 M(+10.8%)
Sep 2017
-
$46.68 M(+16.4%)
Jun 2017
-
$40.10 M(+17.4%)
Mar 2017
-
$34.17 M(+17.6%)
Dec 2016
$100.35 M(+59.2%)
$29.06 M(+26.1%)
Sep 2016
-
$23.04 M(-11.2%)
Jun 2016
-
$25.96 M(+16.5%)
Mar 2016
-
$22.28 M(+11.1%)
Dec 2015
$63.04 M(+58.7%)
$20.05 M(+26.1%)
Sep 2015
-
$15.90 M(+5.4%)
Jun 2015
-
$15.08 M(+25.7%)
Mar 2015
-
$12.00 M(-16.0%)
Dec 2014
$39.73 M(+89.2%)
$14.29 M(+38.9%)
Sep 2014
-
$10.29 M(+25.5%)
Jun 2014
-
$8.20 M(+17.9%)
Mar 2014
-
$6.95 M
Dec 2013
$21.00 M
-

FAQ

  • What is Blueprint Medicines annual total operating expenses?
  • What is the all time high annual operating expenses for Blueprint Medicines?
  • What is Blueprint Medicines annual operating expenses year-on-year change?
  • What is Blueprint Medicines quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Blueprint Medicines?
  • What is Blueprint Medicines quarterly operating expenses year-on-year change?

What is Blueprint Medicines annual total operating expenses?

The current annual operating expenses of BPMC is $722.86 M

What is the all time high annual operating expenses for Blueprint Medicines?

Blueprint Medicines all-time high annual total operating expenses is $796.33 M

What is Blueprint Medicines annual operating expenses year-on-year change?

Over the past year, BPMC annual total operating expenses has changed by +$8.07 M (+1.13%)

What is Blueprint Medicines quarterly total operating expenses?

The current quarterly operating expenses of BPMC is $175.23 M

What is the all time high quarterly operating expenses for Blueprint Medicines?

Blueprint Medicines all-time high quarterly total operating expenses is $411.08 M

What is Blueprint Medicines quarterly operating expenses year-on-year change?

Over the past year, BPMC quarterly total operating expenses has changed by -$5.77 M (-3.19%)